非心脏手术中大剂量羟乙基淀粉130/0.4容量治疗的可行性
被引量:1
摘要
羟乙基淀粉(HES)已广泛应用于容量治疗,可有效地维持血管内容量和组织灌注,其扩容效应和副作用与分子量及取代级有关^[1]。HES可抑制凝血功能,且大剂量HES有血液稀释效应^[2],在机体内经肝脏代谢后从肾脏清除^[3],因此输注大剂量HES可能损害肾功能,目前临床推荐6%HES 130/0.4的每日最大剂量为33ml/kg,但由于其分子量和取代级降低,安全性进一步提高。有研究表明重症颅脑损伤患者每日给予6%HES 130/0.4(70ml/kg)具有良好的安全性^[4]。本研究拟评价非心脏手术中大剂量(50ml/kg)6%HES 130/0.4的安全性和有效性。
出处
《中华麻醉学杂志》
CAS
CSCD
北大核心
2008年第7期663-665,共3页
Chinese Journal of Anesthesiology
参考文献10
-
1Lang K, Boldt J, Suttner S, et al. Colloids verus erystalloids and tissue oxygen tension in patitents undergoing major abdominal surgery. Anesth Aalg, 2001, 93. 405-409.
-
2Niemi TT, Suojaranta-Ylinen RT, Kukkonen SI, et al. Gelatin and hydroxyethyl starch, but not albumin, impair hemostasis after cardiac surgery. Anesth Analg,2006, 102: 998-1006.
-
3Jungheinrich C, Scharpf R, Wargenau M, et al. The pharmacokinetics and tolerability of an intravenous infusion of the new hydroxyethyl starch 130/0.4 ( 6%, 500ml ) in mild-to-severe renal impairment. Anesth Analg, 2002, 95: 544-551.
-
4Neff TA, Doelberg M, Jungheinrich C, et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg, 2003, 96: 1453-1459.
-
5Van der Linden PJ, De Herr SG, Daper A, et al. 3.5% urealinked gelatin is as effective as 6% HES 200/0.5 for volume management in cardiac surgery patients. Can J Anaesth,2004, 51:236-241.
-
6Nielsen VG. Colloids decrease clot propagation and strength: role of factor Ⅷ-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiol Scand, 2005,49 : 163-171.
-
7Niemi TT, Kuitunen A. Artificial colloids impair haemostasis, An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiol Scand,2005, 49: 373-378.
-
8Haisch G, Boldt J, Krebs C, et al. Influence of a new hydroxyethyl starch preparation (HES 130/0.4) on coagulation in cardiac surgical patients. J Cardiothorac Vasc Anesth ,2001, 15: 3163-3121.
-
9张国庆,李悦,李轶聪,关秀茹,冯磊光.6%羟乙基淀粉急性超容性血液稀释对开胸手术患者围术期肾功能的影响[J].中华麻醉学杂志,2004,24(6):422-424. 被引量:13
-
10Kasper SM, Meinert P, Kampe S, et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended dose. Anesthesiology, 2003, 99: 42-47.
二级参考文献5
-
1周晓光.血、尿α_1—微球蛋白测定及其对肾功能的评价[J].国外医学(临床生物化学与检验学分册),1994,15(2):53-55. 被引量:34
-
2Haskell PL, Tannenberg AM.Elevated urinary specific gravity in acute oliguric renal failure due to hetastarch administration. N Y State J Med,1988,88: 387-388.
-
3Legendre C, Thervet E, Page B, et al. Hydroxyethylstarch and osmoticnephrosis-like lesions in kidney transplantation. Lancet , 1993,342: 248-249.
-
4马骐,张涛.最新一代血浆代用品——中分子羟乙基淀粉(贺斯)[J].德国医学,1999,16(4):241-241. 被引量:48
-
5赵鹤龄,朱喜春,高应雪,赵砚丽,陈伯銮.麻醉和手术对肾小球和肾小管功能的影响[J].中华麻醉学杂志,2000,20(10):597-599. 被引量:10
共引文献12
-
1张锐,王国年.急性高容量血液稀释对胃肠道肿瘤患者围术期肾功能的影响[J].吉林医药学院学报,2008,29(2):72-75. 被引量:1
-
2袁福利,黑子清,陈秉学,吴昌彬,靳三庆,徐康清,刘克玄.羟乙基淀粉和琥珀酰明胶急性高容血液稀释对兔肾脏的影响[J].中华麻醉学杂志,2006,26(8):760-762. 被引量:7
-
3尹立军,张守林,李文硕.心血管手术肾保护的研究进展[J].中国煤炭工业医学杂志,2007,10(3):247-249.
-
4董铁立,马孝武,王春亭.术前急性高容量血液稀释对老年开胸手术患者肾功能的影响[J].郑州大学学报(医学版),2007,42(2):273-276. 被引量:8
-
5戴国鹏.胶体溶液急性高容量血液稀释在胸腹部手术中的应用[J].右江医学,2008,36(1):15-16. 被引量:2
-
6王杨,王天元.胶体行急性高容量血液稀释对肾功能的影响[J].哈尔滨医科大学学报,2008,42(3):281-283. 被引量:2
-
7胡美,徐三荣.急性高容血液稀释联合控制性降压对老年肿瘤患者术中血流动力学和肾功能的影响[J].江苏大学学报(医学版),2010,20(5):436-439. 被引量:2
-
8李毓,李兰英.急性高容量血液稀释对老年神经外科手术患者肾功能的影响[J].当代医学,2011,17(4):45-46. 被引量:4
-
9李友明.胶体在普外科中的应用[J].中国当代医药,2011,18(7):160-160.
-
10黄刚红.16例肝功能异常患者手术麻醉的探讨[J].中国卫生产业,2011,8(6):89-89.
同被引文献9
-
1Tian J,Lin X,Guan R,et al.The effects of hydroxyethyl starch on lung capillary permeability in endotoxic rats and possible mechanisms.Anesth Analg,2004,98(3):768-744.
-
2Lank K,Suttner S,Boldt J,et al.Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery.Can J Anaesth,2003,50(10),1009-1016.
-
3Boldt J,Ducke M,Kumle B,et al.Influence of different volume replacement strategies on inflammation and endothelial activation in the elderly undergoing major abdominal surgery.Intensive Care Med,2004,30(3):416-422.
-
4Handrigan MT,Bums AR,Doimachie EM,et al.Hydroxyethyl starch inhibits neutrophil adhesion and transendothelial migration.Shock,2005,24(5):434-439.
-
5Wiggers WC,Ingraham BC.Hemorrhage shock:definition and criteria for its diagnosis.J Clin Invest,1946,25(1):30-36.
-
6Neff TA,Doelberg M,Wargenau M,et al.Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury.Anesth Analg,2003,96(5):1453-1459.
-
7Diehl KH,Hull R,Morton D,et al.A good practice guide to the administration of substances and removal of blood,including routes and volumes.J Appl Toxicol,2001,21 (1):15-23.
-
8Dillon J,Lynch LJ,Myers R,et al.A bioassay of treatment of hemorrhagic shock.Arch Surg,1966,93(7):537-555.
-
9陈畅,王焱林,王成夭,张宗泽.Toll样受体4在失血性休克复苏致小鼠急性肺损伤中的作用[J].中华麻醉学杂志,2008,28(9):820-823. 被引量:3
-
1张秀华,黄宇光.围术期羟乙基淀粉容量治疗的安全性[J].临床麻醉学杂志,2006,22(12):937-938. 被引量:17
-
2姚媛媛,周海燕,范雯,王屹,李剑.6%羟乙基淀粉200/0.5氯化钠注射液对全麻骨科手术患者容量治疗的效果[J].中华麻醉学杂志,2009,29(4):383-384. 被引量:3
-
3刘燕君,罗波,邱信华,胡琳.羟乙基淀粉容量治疗对高龄病人手术的血流动力学影响[J].现代医院,2006,6(6):58-59. 被引量:1
-
4张冬林,刘东,方淑贤,丁玉峰,杜光.2007~2009年武汉地区血浆代用品应用分析[J].医药导报,2010,29(12):1656-1658. 被引量:3
-
5叶穗雯.血浆代用品的应用现状和研究进展[J].中山大学学报论丛,2005,25(5):289-292. 被引量:8
-
6张桂春,孙丽娟,张凌红,赵政.二甲双胍在大鼠体内的药动学和组织分布[J].中国新药与临床杂志,2008,27(3):202-206. 被引量:9
-
7向晓琴,王其南,钱元恕,杜维昭,何海霞,朱治本.静脉滴注乳酸环丙沙星的人体药物动力学[J].重庆医科大学学报,1995,20(4):254-257.
-
8于璟,曹慧玲,赵明,季晓鹏.糖尿病肾病病人血清瘦素水平的变化[J].中国基层医药,2003,10(5):390-391. 被引量:1
-
9覃建明.乌司他丁的药理作用及临床应用进展[J].中国医药导报,2008,5(11):19-20. 被引量:29
-
10李星霞,余奇,郭澄.羟乙基淀粉类血浆代用品的研究进展[J].药学服务与研究,2010,10(2):138-141. 被引量:13